Henry Schein, Inc. (HSIC) stock analysis

Healthcare · Medical Distribution

From the 10-K filed 2026-02-24

Business type: Franchise

How it makes money

It earns revenue by distributing medical products, software, and services to office-based practitioners who require frequent, small-quantity supply deliveries.

Henry Schein generates revenue across three business segments: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. The distribution segment delivers national and corporate brand consumable merchandise, equipment, and technical and consulting services to office-based dental and medical practitioners, laboratories, and surgery centers. Global Specialty Products manufactures and sells dental implants, biomaterials, endodontic, orthodontic, and orthopedic products. Global Technology develops and distributes practice management software and electronic services.

Because office-based healthcare practitioners have limited space to store inventory, purchasing is defined by frequent, small-quantity orders that require rapid, reliable, and complete fulfillment. Practitioner offices typically rely on a primary distributor to handle these ongoing supply needs.

What protects it: the moat

Management claims its network of distribution centers and manufacturing facilities provides a single supply source that creates a competitive advantage.

The company relies on a physical infrastructure spanning distribution centers and manufacturing facilities globally to support rapid order fulfillment. Management claims that combining this infrastructure with broad product offerings and customer service allows it to serve as a single source of supply, which it regards as a competitive advantage.

Practitioners generally buy supplies from more than one distributor while maintaining one primary supplier. However, the filing provides no independent performance metrics proving that this supply model prevents competitors from capturing market share.

What growth costs

It invests capital in organic growth and strategic acquisitions to expand its specialty brands, technology offerings, and global distribution network.

The company relies on reinvestment to maintain and expand its operations across organic initiatives and strategic acquisitions. Keeping its competitive positioning requires ongoing expenditures to sustain its physical distribution footprint and manufacturing capacity.

To drive growth, particularly in specialty products and practice management software, it must continuously acquire or develop new products and services. Its strategy focuses on expanding specialty brands and technology solutions both organically and through acquisitions while seeking operational efficiencies.

What could damage it

Supply interruptions from third-party manufacturers without long-term contracts could prevent order fulfillment and permanently damage customer relationships.

The company depends on third-party manufacturers for a significant volume of distributed products and does not generally maintain long-term contracts with these suppliers. While no single supplier is material, a small group of key vendors supplies a substantial portion of its overall inventory.

If a primary supplier experiences a production halt or regulatory non-compliance, Henry Schein could face an extended supply interruption. If it cannot quickly find replacement sources for high-volume or high-margin products, the resulting inability to fulfill orders would directly disrupt sales, erode practitioner trust, and permanently damage customer relationships.

About Henry Schein, Inc.

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

More on HSIC

Other companies in Medical Distribution